Genome Sequencing

10x Genomics Stock Plummets: Why We’re Not Worried

“Every cell in your body has the same DNA. Except it doesn’t.” That was the title of a 2018 New York Times article that talked about how “the genome doesn’t just vary from person to person, it also varies from cell to cell.” That same year, an article was published by Science discussing a landmark […]

Bionano Genomics Stock: What Exactly Do They Do?

Technological innovation comes and goes constantly. Retail investors should only concern themselves with technology that generates revenue. That’s when something moves from “emerging” to “disruptive.” The time for teams-with-dreams to show traction should be far behind them when they look to the public markets for capital. Special purpose acquisition companies (SPACs) changed that by normalizing […]

Pacific Biosciences Stock Falls While Revenue Rises

One of Warren Buffett’s many notable quotes is that “if you’ve been playing poker for half an hour and you still don’t know who the patsy is, you’re the patsy.” In the investing world, these people are called bag holders. They’ll buy a stock when it’s close to peaking and then hold it stubbornly until […]

An Update on Long-Read Sequencing Stocks

Spending an afternoon on the Oxford campus is a special experience that opens your eyes to the possibilities of youth. As you sip your shandy and watch the students scurry by, you start to realize that while some academics dedicate their entire lives to benefiting humanity, others of us can barely manage to keep our […]

What’s Up With Illumina’s Acquisition of GRAIL?

If you want to land a job at a top investment bank, there’s an expectation that you’ve read certain material. Even though prop trading desks have gone the way of the dodo, books like Liar’s Poker and Reminiscences of a Stock Operator are must-reads. So is the 592-page monster, Barbarians at the Gate, a glimpse […]

Oxford Nanopore Stock: The Internet of Living Things

If you took all the stocks in the world and put them in a single basket, about 58% of that combined market cap would be U.S. stocks. If you want to look that number up, just download a fact sheet for the MSCI ACWI IMI Index. All those cryptic acronyms mean that the index includes […]

8 Whole Genome Sequencing Companies for Precision Health

Earlier this year, we picked apart the 23andMe stock offering for genetic testing. The financial picture looked stagnant, with 23andMe (ME) trying to build interest in the company’s FDA-authorized health insights and a subscription service that provides access to additional reports as they become available. As we noted in the article, the company’s most valuable […]

Why is Illumina’s Stock Price Falling?

Fewer than half of Americans own a passport. Some say that’s because their own backyard is such a big one. The half of our audience that hails from there may not be aware of what’s happening with global travel because they’re blissfully watching the stock market soar inexplicably. According to the World Tourism Barometer, international […]

A Blood Test That Uses Next-Generation Sequencing

If you arrived at this story wondering if someone had found a new way to detect the coronavirus, we’re sorry to disappoint you. This article has no direct connection to the pandemic that is emptying your 401K and threatening the lives of your grandparents, except that we will be talking about viruses, bacteria, and other […]

The 10X Genomics IPO and Single-Cell Sequencing

Over the last few weeks, pundits have been tearing apart the WeWork Initial Public Offering (IPO), and uncovering all kinds of things to write about. It’s a company that’s raised some eyebrows because of their burn rate (between $150 – 200 million a month) and the company’s vague business model which some have described as […]